Yemen

in page functions
[French]
Yemen
Total population (2018) 28,758,258
Birth cohort (2018) 870,107
Surviving Infants (surviving to 1 year per year, 2018) 828,275
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2015) 2.61
Gross Nation Income (per capita US$, 2015) 1,140
Co-financing group (2018) Preparatory transition
No. of districts/territories (2017) 333

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Yemen

Type of support

Approvals

2001-2022 (US$)
(22 Jun 2018)

Commitments

2001-2022 (US$)
(22 Jun 2018)

Disbursements

2000-2018 (US$)
(22 Jun 2018)

% Disbursed

(22 Jun 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $250,567,817 $250,567,817 $242,987,784
Health system strengthening (HSS 1) $6,335,000 $6,335,000 $6,335,000 100%
Health system strengthening (HSS 2) $17,639,234 $17,639,234 $14,279,312 81%
Immunisation services support (ISS) $5,049,500 $5,049,500 $5,049,500 100%
Injection Safety Devices (NVS) $949,344 $949,344 $1,208,393 127%
Injection safety support (INS) $1,194,757 $1,194,757 $1,194,757 100%
IPV (NVS) $5,321,103 $5,321,103 $4,238,178 80%
Measles-Rubella (NVS) $8,313,136 $8,313,136 $8,313,136 100%
MR - Operational costs (OPC) $7,533,500 $7,533,500 $7,533,500 100%
Penta (NVS) $73,476,337 $73,476,337 $77,029,817 105%
Penta - campaign (NVS) $1,849,000 $1,849,000 $1,489,000 81%
Pneumo (NVS) $96,818,128 $96,818,128 $93,803,903 97%
Rotavirus (NVS) $22,640,778 $22,640,778 $19,602,988 87%
Td - campaign (NVS) $1,339,000 $1,339,000 $801,300 60%
Vaccine Introduction Grant (VIG) $2,109,000 $2,109,000 $2,109,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 83%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2012) 59.70%
Household survey: DTP3 coverage for female (2012) 59.60%
Household survey: Last DTP3 survey (2012) 60%
% districts achieving > 80% DTP3 coverage (2017) 62%
% districts achieving < 50% DTP3 coverage (2017) 11%
MCV WHO/UNICEF estimates (2016) 70%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$36,501,069 $206,486,715

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

06 June 2018

Gavi Board meeting, 6-7 June 2018

The Gavi Board meeting was held in Geneva, Switzerland on 6-7 June 2018.

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

15 June 2017

DRC: a nurse vaccinates a child

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

close icon

modal window here